Future Indications. If the Parties agree to develop a Drug Product for Future Indications, each Party shall and hereby does grant to the other a worldwide, fully paid up, non-exclusive and royalty-free license to use its respective Background Technology and Collaboration Technology for development for Future Indications.
Appears in 3 contracts
Sources: Collaboration Agreement, Collaboration Agreement (Entasis Therapeutics LTD), Collaboration Agreement (Entasis Therapeutics LTD)